Anteris Technologies' Subsidiary Launches IPO Roadshow in US

MT Newswires Live

Dec 10, 2024

Anteris Technologies' (ASX:AVR) subsidiary, Anteris Technologies Global Corp. (ATGC), launched the roadshow for its proposed initial public offering of 14.8 million common shares in the US, according to a Tuesday filing with the Australian bourse.

ATGC applied to list its common stock on the Nasdaq Global Market under the ticker symbol "AVR." The unit intends to grant the underwriters a 30-day option to purchase up to an additional 2.2 million shares at the IPO price, less underwriting discounts and commissions, the filing stated.

Following the offering, ATGC intends to list its CHESS Depositary Interests on the Australian Securities Exchange under the same symbol.

Proceeds will be used to fund the ongoing development of Anteris' DurAVR transcatheter heart valve.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2490303198"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2490303198\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2490303198?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-10 09:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490303198","market":"hk","top_or_hot":-1,"title":"Anteris Technologies' Subsidiary Launches IPO Roadshow in US","media":"MT Newswires Live","content":"<html><body><p> Anteris Technologies' (ASX:AVR) subsidiary, <a href=\"https://laohu8.com/S/AVRDB.AU\">Anteris Technologies Global Corp</a>. (ATGC), launched the roadshow for its proposed initial public offering of 14.8 million common shares in the US, according to a Tuesday filing with the Australian bourse.</p><p>ATGC applied to list its common stock on the Nasdaq Global Market under the ticker symbol \"AVR.\" The unit intends to grant the underwriters a 30-day option to purchase up to an additional 2.2 million shares at the IPO price, less underwriting discounts and commissions, the filing stated.</p><p>Following the offering, ATGC intends to list its CHESS Depositary Interests on the Australian Securities Exchange under the same symbol.</p><p>Proceeds will be used to fund the ongoing development of Anteris' DurAVR transcatheter heart valve.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Anteris Technologies' Subsidiary Launches IPO Roadshow in US</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnteris Technologies' Subsidiary Launches IPO Roadshow in US\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-10 09:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Anteris Technologies' (ASX:AVR) subsidiary, <a href=\"https://laohu8.com/S/AVRDB.AU\">Anteris Technologies Global Corp</a>. (ATGC), launched the roadshow for its proposed initial public offering of 14.8 million common shares in the US, according to a Tuesday filing with the Australian bourse.</p><p>ATGC applied to list its common stock on the Nasdaq Global Market under the ticker symbol \"AVR.\" The unit intends to grant the underwriters a 30-day option to purchase up to an additional 2.2 million shares at the IPO price, less underwriting discounts and commissions, the filing stated.</p><p>Following the offering, ATGC intends to list its CHESS Depositary Interests on the Australian Securities Exchange under the same symbol.</p><p>Proceeds will be used to fund the ongoing development of Anteris' DurAVR transcatheter heart valve.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XJO.AU","symbol_name":"标普/澳交所 200指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2490303198","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490303198","pubTimestamp":1733795425,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Anteris Technologies'  subsidiary, Anteris Technologies Global Corp. , launched the roadshow for its proposed initial public offering of 14.8 million common shares in the US, according to a Tuesday filing with the Australian bourse.ATGC applied to list its common stock on the Nasdaq Global Market under the ticker symbol \"AVR.\" The unit intends to grant the underwriters a 30-day option to purchase up to an additional 2.2 million shares at the IPO price, less underwriting discounts and commissions, the filing stated.Following the offering, ATGC intends to list its CHESS Depositary Interests on the Australian Securities Exchange under the same symbol.Proceeds will be used to fund the ongoing development of Anteris' DurAVR transcatheter heart valve.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XJO.AU":"标普/澳交所 200指数","XAO.AU":"标普/澳交所 普通股指数","BK7126":"医疗保健用品","XKO.AU":"标普/澳交所 300指数","BK7007":"医疗保健设备","AVR.AU":"ANTERIS TECHNOLOGIES LTD"},"translate_title":"Anteris Technologies子公司在美国启动IPO路演","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XAO.AU":0.78,"XJO.AU":0.78,"XKO.AU":0.78,"AVR.AU":0.9},"content_text":"Anteris Technologies' (ASX:AVR) subsidiary, Anteris Technologies Global Corp. (ATGC), launched the roadshow for its proposed initial public offering of 14.8 million common shares in the US, according to a Tuesday filing with the Australian bourse.ATGC applied to list its common stock on the Nasdaq Global Market under the ticker symbol \"AVR.\" The unit intends to grant the underwriters a 30-day option to purchase up to an additional 2.2 million shares at the IPO price, less underwriting discounts and commissions, the filing stated.Following the offering, ATGC intends to list its CHESS Depositary Interests on the Australian Securities Exchange under the same symbol.Proceeds will be used to fund the ongoing development of Anteris' DurAVR transcatheter heart valve.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}